Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Total Non-Current Liabilities: 2013-2025

Historic Total Non-Current Liabilities for MediWound (MDWD) over the last 12 years, with Sep 2025 value amounting to $18.0 million.

  • MediWound's Total Non-Current Liabilities rose 20.71% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 20.71%. This contributed to the annual value of $15.8 million for FY2024, which is 5.60% down from last year.
  • According to the latest figures from Q3 2025, MediWound's Total Non-Current Liabilities is $18.0 million, which was up 1.13% from $17.8 million recorded in Q2 2025.
  • MediWound's 5-year Total Non-Current Liabilities high stood at $27.0 million for Q4 2022, and its period low was $11.4 million during Q1 2023.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $16.6 million (2023), whereas its average is $15.7 million.
  • Per our database at Business Quant, MediWound's Total Non-Current Liabilities spiked by 98.79% in 2022 and then crashed by 38.11% in 2023.
  • Quarterly analysis of 5 years shows MediWound's Total Non-Current Liabilities stood at $13.6 million in 2021, then skyrocketed by 98.79% to $27.0 million in 2022, then plummeted by 38.11% to $16.7 million in 2023, then fell by 5.60% to $15.8 million in 2024, then rose by 20.71% to $18.0 million in 2025.
  • Its last three reported values are $18.0 million in Q3 2025, $17.8 million for Q2 2025, and $15.9 million during Q1 2025.